BACKGROUND: Older Americans are facing an epidemic of chronic diseases and are thus exposed to anticholinergics (ACs) that might negatively affect their risk of developing mild cognitive impairment (MCI) or dementia. OBJECTIVE: To investigate the association between impairment in cognitive function and previous AC exposure. DESIGN: A retrospective cohort study. SETTING: Primary care clinics in Indianapolis, Indiana. PARTICIPANTS: A total of 3690 older adults who have undergone cognitive assessment and had a 1-year medication-dispensing record. OUTCOME: Cognitive function was measured in two sequential steps: a two-step screening process followed by a formal diagnostic process for participants with positive screening results. EXPOSURE: Three patterns of AC exposure were defined by the duration of AC exposure, the number of AC medications dispensed at the same time, and the severity of AC effects as determined by the Anticholinergic Cognitive Burden list. RESULTS: Compared with older adults with no AC exposure and after adjusting for age, race, gender, and underlying comorbidity, the odds ratio for having a diagnosis of MCI was 2.73 (95% confidence interval, 1.27-5.87) among older adults who were exposed to at least three possible ACs for at least 90 days; the odds ratio for having dementia was 0.43 (95% confidence interval, 0.10-1.81). CONCLUSION: Exposure to medications with severe AC cognitive burden may be a risk factor for developing MCI.
BACKGROUND: Older Americans are facing an epidemic of chronic diseases and are thus exposed to anticholinergics (ACs) that might negatively affect their risk of developing mild cognitive impairment (MCI) or dementia. OBJECTIVE: To investigate the association between impairment in cognitive function and previous AC exposure. DESIGN: A retrospective cohort study. SETTING: Primary care clinics in Indianapolis, Indiana. PARTICIPANTS: A total of 3690 older adults who have undergone cognitive assessment and had a 1-year medication-dispensing record. OUTCOME: Cognitive function was measured in two sequential steps: a two-step screening process followed by a formal diagnostic process for participants with positive screening results. EXPOSURE: Three patterns of AC exposure were defined by the duration of AC exposure, the number of AC medications dispensed at the same time, and the severity of AC effects as determined by the Anticholinergic Cognitive Burden list. RESULTS: Compared with older adults with no AC exposure and after adjusting for age, race, gender, and underlying comorbidity, the odds ratio for having a diagnosis of MCI was 2.73 (95% confidence interval, 1.27-5.87) among older adults who were exposed to at least three possible ACs for at least 90 days; the odds ratio for having dementia was 0.43 (95% confidence interval, 0.10-1.81). CONCLUSION: Exposure to medications with severe AC cognitive burden may be a risk factor for developing MCI.
Authors: Antonella Caccamo; Salvatore Oddo; Lauren M Billings; Kim N Green; Hilda Martinez-Coria; Abraham Fisher; Frank M LaFerla Journal: Neuron Date: 2006-03-02 Impact factor: 17.173
Authors: Malaz Boustani; Anthony J Perkins; Chris Fox; Fred Unverzagt; Mary Guerriero Austrom; Bridget Fultz; Siu Hui; Christopher M Callahan; Hugh C Hendrie Journal: Int J Geriatr Psychiatry Date: 2006-06 Impact factor: 3.485
Authors: Christopher M Callahan; Frederick W Unverzagt; Siu L Hui; Anthony J Perkins; Hugh C Hendrie Journal: Med Care Date: 2002-09 Impact factor: 2.983
Authors: Noll Campbell; Malaz Boustani; Tony Limbil; Carol Ott; Chris Fox; Ian Maidment; Cathy C Schubert; Stephanie Munger; Donna Fick; David Miller; Rajesh Gulati Journal: Clin Interv Aging Date: 2009-06-09 Impact factor: 4.458
Authors: R Ross Welliver; Jessie J Polanco; Richard A Seidman; Anjali K Sinha; Melanie A O'Bara; Zainab M Khaku; Diara A Santiago González; Akiko Nishiyama; Jurgen Wess; M Laura Feltri; Pablo M Paez; Fraser J Sim Journal: J Neurosci Date: 2018-06-29 Impact factor: 6.167
Authors: Babar A Khan; Anthony Perkins; Siu L Hui; Sujuan Gao; Noll L Campbell; Mark O Farber; Malaz A Boustani Journal: Crit Care Med Date: 2016-09 Impact factor: 7.598
Authors: Shannon L Risacher; Brenna C McDonald; Eileen F Tallman; John D West; Martin R Farlow; Fredrick W Unverzagt; Sujuan Gao; Malaz Boustani; Paul K Crane; Ronald C Petersen; Clifford R Jack; William J Jagust; Paul S Aisen; Michael W Weiner; Andrew J Saykin Journal: JAMA Neurol Date: 2016-06-01 Impact factor: 18.302
Authors: T Frühwald; M Weissenberger-Leduc; C Jagsch; K Singler; S Gurlit; W Hofmann; B Böhmdorfer; B Iglseder Journal: Z Gerontol Geriatr Date: 2014-07 Impact factor: 1.281